Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a review
Alain MonnierInstitut Régional Fédératif du Cancer (IFRC), Centre Hospitalier Belfort-Montbéliard, Montbéliard, FranceAbstract: Aromatase inhibitors (AIs) are becoming more widely used than tamoxifen as adjuvant hormonal therapy for postmenopaus...
Saved in:
Main Author: | Alain Monnier (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term efficacy and safety of anastrozole for adjuvant treatment of early breast cancer in postmenopausal women
by: Sharath Gangadhara, et al.
Published: (2009) -
Adjuvant endocrinotherapy of postmenopausal patients with breast cancer
by: V. F. Semiglazov, et al.
Published: (2014) -
Efficacy and safety of goserelin combined with adjuvant chemotherapy in premenopausal women with breast cancer
by: Yang Wang, et al.
Published: (2015) -
Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
by: Enrico M Messalli, et al.
Published: (2009) -
Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis
by: Inderjeeth CA, et al.
Published: (2014)